海吉亚医疗控股有限公司(06078)于2026年2月12日公告，回购股份数量为140,000股，占回购前公司已发行股本(不包括库藏股)的约0.0227%。本次回购价格区间介于每股14.22港元至14.27港元，耗资总额约1,993,922港元。
回购完成后，公司已发行股本总数仍为618,499,000股，其中616,475,400股为已发行股份(不包括库藏股)，2,023,600股为库藏股。根据公告，回购授权于2025年6月27日获通过，公司最多可回购61,849,900股，截至此次回购，累计已回购2,023,600股。
公司确认已遵守相关上市规则与法律程序。上述公告由执行董事任爱签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.